Biohazardous microplates — plates containing infectious agents, primary human samples, or recombinant genetic material — are one of the most frequently mishandled consumables in the life science laboratory. Their open-well format, large surface area, and high sample density create multiple opportunities for aerosol generation, cross-contamination, and accidental exposure during routine operations such as pipetting, washing, and lid removal. Understanding the specific hazards associated with plate-based biological work, and implementing containment and decontamination measures proportionate to the risk, is essential for laboratories that process clinical specimens, conduct cell-based assays, or run high-throughput immunoassays with human-derived material. This article outlines the biosafety requirements and procedural best practices that apply across the most common microplate workflows — all of which are performed on an instrument platform discussed in detail in this overview of microplate reader configuration and performance.

How to assess biosafety risk before running biohazardous microplate assays

Every biohazardous microplate workflow must begin with a formal risk assessment that identifies the biosafety level (BSL) appropriate for the organisms or materials being handled. BSL-1 applies to agents not known to cause disease in healthy adults and requires standard microbiological practices — hand washing, no mouth pipetting, and appropriate disposal of contaminated materials. BSL-2 applies to agents associated with human disease where the primary exposure routes are percutaneous injury, ingestion, or mucous membrane contact; this category covers the majority of clinical diagnostic and cell biology laboratories running plate-based enzyme-linked immunosorbent assay (ELISA) or cell viability workflows with primary patient samples.

The risk assessment must account not just for the biological agent itself but for the specific manipulations being performed. Plate washing steps — whether manual or automated — generate aerosols from rapidly dispensed and aspirated liquid, and represent a higher-exposure event than simple pipetting into sealed wells. Sealing plates before centrifugation, using adhesive films rated for the intended centrifuge speed, eliminates the risk of liquid ejection from unsealed wells — an event that can contaminate large areas of the work surface rapidly. Any procedure involving plates at BSL-2 or above should be reviewed against the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL) to confirm that engineering controls and work practices are appropriate for the agent and procedure combination.

PPE and biosafety cabinet requirements for biohazardous microplate handling

Personal protective equipment (PPE) for biohazardous microplate handling must be selected based on the BSL designation and the specific manipulations involved, not on general laboratory convention. At minimum, BSL-2 microplate work requires a laboratory coat, nitrile gloves, and eye protection; a face shield or splash goggles are required whenever plates are being opened, washed, or centrifuged without sealed lids. Double-gloving is recommended for workflows involving high-titer infectious agents or concentrated viral stocks in plate format.

Interested in lab tools and techniques?

Register for a FREE Lab Manager account to subscribe to our Lab Tools & Techniques Newsletter.

Subscribe for Free

The primary containment barrier for BSL-2 plate work is a Class II Type A2 biological safety cabinet (BSC). All plate loading, sample addition, and lid removal steps should be performed within the BSC with the sash at the correct working height and the cabinet blower confirmed operational before work begins. Plates should never be opened outside a BSC when they contain viable infectious agents, regardless of how brief the exposure period is expected to be. The following PPE requirements apply across BSL-1 and BSL-2 microplate workflows:

• BSL-1: lab coat, gloves; standard bench work acceptable for non-infectious material
• BSL-2 (non-aerosol-generating steps): lab coat, gloves, safety glasses
• BSL-2 (aerosol-generating steps such as plate washing): lab coat, double gloves, face shield, BSC required
• BSL-2 (centrifugation): sealed plates or sealed centrifuge buckets mandatory; open rotor operation not permitted
• All levels: dedicated plate-handling equipment (multichannel pipettes, plate sealers) that does not leave the designated work zone

Minimizing aerosol generation and cross-contamination in biohazardous microplate workflows

Aerosol generation is the primary route of exposure in plate-based biological work and occurs most readily during three operations: liquid dispensing into open wells, plate washing with automated washers, and removal of adhesive seals. Dispensing speed directly controls aerosol output — reducing aspiration and dispense rates on automated liquid handlers substantially lowers the aerosol burden in the work area without meaningfully affecting assay performance. When handling biohazardous samples in automated laboratory workflows, validating the liquid handler's aerosol output at the intended dispense speed is a recommended step before routine use with infectious material.

Adhesive plate seals should be removed slowly and at an oblique angle within the BSC, directing the seal away from the operator's face and toward the back wall of the cabinet. Rapid seal removal from plates containing liquid generates a fine mist from the well surfaces — a risk that is amplified in higher-density 384-well formats where per-well volumes are smaller and surface tension effects are greater. Cross-contamination between wells is an additional concern when seals are reused; a single-use seal policy should be treated as a biosafety requirement, not merely a quality control preference, for any plate containing infectious material.

How to decontaminate biohazardous microplates: methods, contact times, and instrument care

Decontamination of biohazardous microplates must be performed before the plates leave the laboratory or are discarded into general waste. The appropriate method depends on the nature of the biological material, the plate format, and available equipment.

Liquid disinfectant concentration and contact time are both critical variables that are frequently underestimated in routine laboratory practice. A 10% bleach solution left on a surface for five minutes does not achieve the same degree of inactivation as a 20–30 minute exposure — particularly for non-enveloped viruses such as norovirus or parvovirus, which are substantially more resistant to chemical disinfection than enveloped viruses like influenza or SARS-CoV-2. Bleach solutions should be prepared fresh daily by mixing one part commercial bleach with nine parts water, as hypochlorite degrades rapidly on exposure to light, heat, and organic material, and a degraded solution provides a false sense of security without delivering the expected antimicrobial activity.

Plate reader surfaces that have been exposed to biohazardous plates — including the plate carrier, drawer, and any accessible optical components — should be wiped with an appropriate disinfectant at the end of each run. A 70% ethanol wipe is suitable for routine decontamination of instrument surfaces following BSL-1 or BSL-2 work with non-sporulating agents. Stronger disinfectants such as dilute bleach solution may be required following spills or following work with more resistant organisms, but compatibility with instrument materials should be confirmed with the manufacturer before use.

Biohazardous microplate waste disposal and documentation requirements

Biohazardous microplate waste must be collected, labeled, and disposed of in accordance with institutional biosafety protocols and applicable local regulations. Plates, tips, seals, and other consumables that have contacted infectious material must be placed in biohazard-labeled bags or rigid biohazard containers immediately after use — not accumulated open on the bench between runs. Liquid waste from plate washes containing infectious material should be collected in a sealed flask treated with a validated disinfectant before drain disposal, following institutional guidelines for the specific agent class.

Plates containing recombinant or synthetic nucleic acid material must be decontaminated prior to disposal regardless of the biosafety level of the host organism, consistent with National Institutes of Health (NIH) guidelines for recombinant DNA research. Documentation of decontamination method, date, and responsible personnel should be maintained as part of the laboratory's standard operating procedure (SOP) records, which provides both regulatory compliance evidence and a reference for incident investigation if an exposure event occurs.

Building a layered safety approach for biohazardous microplate workflows

Biohazardous microplate safety depends on consistent application of containment principles at every step — from risk assessment and PPE selection through decontamination and waste documentation. No single control measure is sufficient in isolation; the combination of engineering controls (BSC, sealed plates), work practice controls (aerosol-minimizing dispense speeds, single-use seals), and appropriate PPE provides the layered protection that regulatory frameworks including OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030) and institutional biosafety programs require. Laboratories that routinely process biohazardous plates should review their containment and decontamination SOPs at least annually, updating them as assay formats, plate densities, or biological agents change — since the hazard profile of a 384-well high-titer viral assay differs substantially from a routine BSL-1 colorimetric screen using the same microplate reader.

References

1. Centers for Disease Control and Prevention; National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th ed. US Department of Health and Human Services; 2020. https://www.cdc.gov/labs/bmbl/index.html
2. Occupational Safety and Health Administration. Bloodborne pathogens standard (29 CFR 1910.1030). US Department of Labor. https://www.osha.gov/bloodborne-pathogens

This article was created with the assistance of Generative AI and has undergone editorial review before publishing.